Heraeus Precious Metals GmbH & Co. KG is the pharmaceutical ingredients division of the Heraeus Group, specializing in the production of generic highly potent active pharmaceutical ingredients (HPAPIs) for cancer treatment. The company is the global market leader for platinum-based active ingredients including cisplatin, carboplatin, and oxaliplatin. In 2021, Heraeus made a multi-million euro investment expanding HPAPI manufacturing capacity in Hanau, Germany.
platinum-based HPAPIs, cisplatin/carboplatin/oxaliplatin manufacturing, cytotoxic API production, precious metal pharmaceutical ingredients
1 site worldwide
No reviews available yet.
No documents available.